510(k) Report

510(k) · Cleared

Cleared

Optirad

K993895510(k) TraditionalCleared Jun 2, 2000199-day reviewClass II21 CFR 892.5050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Permedics, Inc. · MUJ System, Planning, Radiation Therapy Treatment

Cleared on Jun 2, 2000 after a 199-day review. The FDA summary names its predicate without a number. 5 later devices descend from it.

Decided
Jun 2, 2000
Review
199 days
Class
Class II
Product code
MUJ
Recalls
None
Predicates
0

5 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2003: 1 descendant cleared2005: 1 descendant cleared2004: 1 descendant cleared2006: 2 descendants cleared200020052010201520202025
  1. This deviceK993895 OptiradPermedics, Inc. · 2000
  2. Descendant · cites it directly · 3 of its ownK032171 AccusoftDirex Systems Corp. · 2003
  3. Descendant · cites it directly · 2 of its ownK042861 OdysseyPermedics, Inc. · 2005 · Recalled
  4. Descendant · 2 generations on · 2 of its ownK040474 AccusoftDirex Systems Corp. · 2004
  5. Descendant · 2 generations on · 1 of its ownK062032 Accusoft, Accusoft XLDirex Systems Corp. · 2006
  6. Descendant · 3 generations on · 0 of its ownK063482 Crossplan / Accusoft-XL V.4.04Direx Systems Corp. · 2006

Most influential descendants

Showing 5 of 5 · See all
  • K032171AccusoftDirex Systems Corp. · 2003 · cites it directly3descendants
  • K042861OdysseyPermedics, Inc. · 2005 · cites it directly2descendants
  • K040474AccusoftDirex Systems Corp. · 2004 · 2 generations on2descendants
  • K062032Accusoft, Accusoft XLDirex Systems Corp. · 2006 · 2 generations on1descendant
  • K063482Crossplan / Accusoft-XL V.4.04Direx Systems Corp. · 2006 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K993895OptiradPermedics, Inc.2000—
+1K032171AccusoftDirex Systems Corp.2003—
+1K042861OdysseyPermedics, Inc.20052
+2K040474AccusoftDirex Systems Corp.2004—
+2K062032Accusoft, Accusoft XLDirex Systems Corp.2006—
+3K063482Crossplan / Accusoft-XL V.4.04Direx Systems Corp.2006—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200310
200410
200510
200620
FIG. 1 — Lineage of K993895, 2000–2006Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MUJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MUJ device

  1. #1 K232799 syngo.via RT Image Suitescore 18.6 · 19 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Rocs TPS
Named without a submission number
—

What descends from it? (5)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K032171AccusoftDirex Systems Corp.20033
K042861OdysseyPermedics, Inc.20052

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K032171 (Direx Systems Corp., 2003) has gone furthest, with 3 descendants of its own.

How does its category compare?

All MUJ devices

MUJ System, Planning, Radiation Therapy Treatment: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MUJ

10in 2025

2007: 42008: 92009: 162010: 112011: 92012: 82013: 52014: 92015: 132016: 52017: 72018: 72019: 92020: 92021: 112022: 82023: 102024: 92025: 102026 (partial year): 9
2007high 16 (2009) · low 4 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MUJ

186in 2025

2007: 67 days median2008: 63 days median2009: 84 days median2010: 56 days median2011: 103 days median2012: 59 days median2013: 64 days median2014: 108 days median2015: 78 days median2016: 80 days median2017: 30 days median2018: 53 days median2019: 56 days median2020: 104 days median2021: 87 days median2022: 168 days median2023: 140 days median2024: 122 days median2025: 186 days median2026 (partial year): 233 days median
2007high 233 (2026) · low 30 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MUJ

2in 2023

2007: 42008: 102009: 112010: 232011: 172012: 42013: 62014: 22015: 72016: 132017: 42018: 32019: 42020: 22021: 42022: 32023: 22026 (partial year): 2
2007high 23 (2010) · low 0 (2024)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MUJ

21in 2025

2007: 242008: 512009: 242010: 782011: 732012: 392013: 332014: 352015: 302016: 272017: 162018: 252019: 252020: 262021: 152022: 222023: 762024: 92025: 21
2007high 78 (2010) · low 9 (2024)2025

MAUDE reports naming product code MUJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007467424
20089631051
200916841124
201011562378
201191031773
2012859439
2013564633
20149108235
20151378730
20165801327
2017730416
2018753325
2019956425
20209104226
20211187415
20228168322
202310140276
2024912209
202510186021
202692332—

What is it indicated for?

The OptiRad software is to be used for the computation, display, evaluation and output documentation of radiation dose estimations to be submitted for independent clinical review and judgement prior to use. The device provides output data in the form of displays and/or hardcopies to guide a physician in selecting the optimum patient treatment plan. It is intended to provide a report to be used by a competent health professional such as a radiation oncologist, medical physicist, radiation therapist or dosimetrist.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K993895: Optirad.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K993895

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026